Vivos Therapeutics (VVOS) said Wednesday it struck a deal to buy the operating assets of The Sleep Center of Nevada for up to $9 million, including $6 million in cash and $1.5 million in shares.
The transaction, expected to close in Q2 or Q3, does not require Vivos shareholder approval, the company said. It plans to secure funding with a senior debt facility, and potential equity financing.
With the acquisition, the company said it plans to make its treatments for obstructive sleep apnea available to thousands of patients in the greater Las Vegas metro area.
Price: 2.10, Change: -0.09, Percent Change: -4.11